NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 47 filers reported holding NEUBASE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,564 | -50.5% | 19,264 | -49.2% | 0.00% | – |
| Q4 2022 | $7,207 | -78.8% | 37,891 | +106.6% | 0.00% | – |
| Q1 2022 | $34,000 | -88.2% | 18,339 | -82.2% | 0.00% | – |
| Q4 2021 | $288,000 | -22.8% | 102,864 | -0.4% | 0.00% | – |
| Q3 2021 | $373,000 | -35.1% | 103,248 | -14.1% | 0.00% | – |
| Q2 2021 | $575,000 | +16.6% | 120,242 | +80.2% | 0.00% | – |
| Q1 2021 | $493,000 | -11.3% | 66,719 | -16.1% | 0.00% | – |
| Q4 2020 | $556,000 | – | 79,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $494,000 | 0.50% |
| CARNEGIE MELLON UNIVERSITY | 939,412 | $986,000 | 0.50% |
| CM Management, LLC | 370,000 | $389,000 | 0.41% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $1,050,000 | 0.40% |
| Sio Capital Management, LLC | 906,445 | $952,000 | 0.36% |
| AIGH Capital Management LLC | 1,027,585 | $1,079,000 | 0.28% |
| Greenlight Capital | 2,727,027 | $2,863,000 | 0.22% |
| Worth Venture Partners, LLC | 256,553 | $249,000 | 0.15% |
| PERKINS CAPITAL MANAGEMENT INC | 81,500 | $86,000 | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $327,000 | 0.01% |